Advertisement
Advertisement
-
Money /

Investment Products

Related Topics:
Stocks
Banking & finance
Staff members dispense medicines at a pharmacy in Wuhan, in central China’s Hubei province, on February 27, 2020. Photo: Xinhua
Two Sessions 2026

Healthcare investors looking to ‘two sessions’ for clarity on drug pricing

Healthcare and insurance sectors will see policy fine-tuning, ‘moral support’ rather than ‘groundbreaking news’ from Beijing, analysts say.

IPO

HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings

Made in China 2025

Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals

Hong Kong stock market

The big cornerstone comeback: what’s driving investors back to Hong Kong IPOs?

After four subdued years, the cornerstone investors that anchor Hong Kong’s IPO market are returning in force, reshaping the deal landscape.

Illustration: Lau Ka-kuen
Illustration: Lau Ka-kuen
Made in China 2025

Chinese healthcare firms expand overseas to support growing expat community

Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.

Banking & finance

Mainland China’s investors pour into Hong Kong-listed drug stocks

An index tracking Stock Connect buying of 40 mainland drug firms gains 9 per cent in a week as China’s industry heft grows.

Advertisement
Advertisement
Advertisement
Made in China 2025

Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal

The deal comes as Chinese novel drug makers are having more say in how their new medicines are developed with global partners.

A view of the Shanghai facility of Fosun Pharma’s biopharma unit Henlius. Photo: Handout
A view of the Shanghai facility of Fosun Pharma’s biopharma unit Henlius. Photo: Handout
Banking & finance

Chinese gold, silver investors face gut check amid volatility, fund suspensions

Some retreat to the sidelines as another fund suspends new investments and futures plunge, while others remain determined to buy the dip.

Hong Kong property

SHKP posts another Sierra Sea sell-out as Hong Kong property rebound strengthens

Fifth consecutive sell-out at Sai Sha development shows recovery gathering pace, with analysts forecasting further price increases ahead.

Banking & finance

The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs

A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.

Healthcare firms now account for about a fifth of the more than 300 listing applications in the city. Photo: Shutterstock
Fintech

Digital finance in 2026: what to expect as pilots move into real-world adoption

While digital money experiments promise greater efficiency, they also risk deeper fragmentation and regulatory pitfalls, experts warn.

Blockchain and Web3 technology are “inherently global”, but real-world applications must be “embedded in regulation and local use cases”, expert says. Photo: Shutterstock
Blockchain and Web3 technology are “inherently global”, but real-world applications must be “embedded in regulation and local use cases”, expert says. Photo: Shutterstock
Made in China 2025

China’s rising biotech clout on show in flurry of billion-dollar licensing deals

A burst of overseas licensing pacts is spotlighting China’s biotech sector, as Jacobio, Coherent Biopharma and Harbour BioMed land deals.

Banking & finance

Gold takes centre stage as Hong Kong builds commodities ecosystem

Hong Kong plans to build an international gold trading centre as part of a wider commodities hub push.

Banking & finance

Hong Kong launches HKEX Tech 100 Index in pivot towards innovation-driven growth

Unveiling of benchmark tracking Hong Kong-listed tech firms comes amid a wave of property stock delistings.

The HKEX Tech 100 Index “covers the leading innovative sectors in our listed issuer universe that have transformed the DNA of Hong Kong’s markets”, says HKEX CEO Bonnie Chan. Photo: Handout
Wealth management

China’s rich step up offshore bets as gold and insurance gain favour

China’s wealthy are shifting more of their portfolios offshore, as they seek to hedge slowing growth, policy risks and low yields at home.

As economic headwinds persist, China’s wealthy are becoming more cautious, using gold and insurance to preserve capital. Photo: XInhua
As economic headwinds persist, China’s wealthy are becoming more cautious, using gold and insurance to preserve capital. Photo: XInhua
Banking & finance

China’s JD.com unit Jingdong Industrials aims for US$412 million Hong Kong IPO

Seven cornerstone investors led by London-based M&G Investments pledge a total of US$170 million.

Banking & finance

From chips to noodles: the newcomers testing Hong Kong’s buoyant IPO market

A wave of billion-dollar offerings is building behind four new listings this week, signalling sustained momentum in Hong Kong’s IPO market.

Advertisement
Advertisement
Advertisement
Banking & finance

Hong Kong taps Value Partners, 9 others to manage US$385 million residency fund

Government investment arm HKIC also names Primavera among managers of CIES IP, which focuses on Hong Kong’s long-term development.

The 10 asset managers appointed span venture capital, private equity, private credit and hedge funds. Photo: Sun Yeung
The 10 asset managers appointed span venture capital, private equity, private credit and hedge funds. Photo: Sun Yeung
Banking & finance

Hong Kong retail funds hit record pace, surpass 2024 full-year total

Gross sales reach US$82.6 billion in the first three quarters as investors pile into fixed-income funds: HKIFA.

Fintech

Hong Kong and Malaysian firms launch tokenised AI infrastructure fund

‘World’s first’ global-grade AI infrastructure tokenised fund gives investors access to growing demand from Asean: Tykhe and Skyvast.

Banking & finance

Asia-Pacific investors brace for market correction in 2026: survey

Top concerns include a potential tech bubble, geopolitical tensions and recession, according to Natixis.

An electronic board at the Lujiazui financial district in Shanghai showing the Shanghai and Shenzhen stock indices. Photo: Reuters
IPO

China’s Unitree Robotics completes pre-IPO tutoring for onshore listing

The unicorn is reportedly aiming for a valuation of up to US$7 billion in a listing on Shanghai’s Nasdaq-style Star Market.

videocam
A Unitree robot seen at the Web Summit in Lisbon last week. Photo: AFP
A Unitree robot seen at the Web Summit in Lisbon last week. Photo: AFP
Banking & finance

Adams Street joins wave of investment firms opening in Hong Kong

‘We want to be closer to both our investors and the investment opportunities that are presenting themselves here,’ managing partner says.

Banking & finance

Hong Kong moves from theory to practice with real-value tokenised money, asset deals

Live transfers of tokenised deposits signal Hong Kong’s shift from proof of concept to production-grade digital-asset settlement.

Banking & finance

Hong Kong prices world’s first bonds with tokenised settlement

US$1.3 billion issuance helps ‘reinforce the vision’ for Hong Kong as a global hub for digital assets, monetary authority chief says.

Hong Kong is at “the forefront of financial innovation”, says HSBC co-CEO for Asia and the Middle East. Photo: Elson Li
Help preserve 120 years of quality journalism.
SUPPORT NOW